XTX Topco’s Purple Biotech PPBT Stock Holding History

XTX Topco’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-145	Closed	-$19.5K	–	2352
2024 Q1	$19.5K	Buy	145 +77	+113%	+$11K	﹤0.01%	1608
2023 Q4	$10.6K	Buy	+68	New	+$15.1K	﹤0.01%	1424

Other funds holding PPBT

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

WAOI

Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

XTX Topco's PPBT Position: Q2 2024 in Review

XTX Topco sold out of Purple Biotech (PPBT) in Q2 2024, closing a stake of 145 shares — an estimated $19.5K sold.

XTX Topco first reported a position in PPBT in Q4 2023 and held it in 2 quarters. The position peaked at $19.5K in Q1 2024. 19 funds tracked by Wall St. Rank hold PPBT as of Q2 2024.

XTX Topco reported no remaining Purple Biotech position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 145 Purple Biotech shares in Q2 2024, an estimated $19.5K.
XTX Topco first reported a position in Purple Biotech in Q4 2023 and held it in 2 quarters.
XTX Topco's Purple Biotech position peaked at $19.5K in Q1 2024.
19 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.